SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-025546
Filing Date
2019-05-13
Accepted
2019-05-13 13:43:18
Documents
39
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv520739_10q.htm 10-Q 226130
2 EXHIBIT 31.1 tv520739_ex31-1.htm EX-31.1 10185
3 EXHIBIT 31.2 tv520739_ex31-2.htm EX-31.2 10035
4 EXHIBIT 32.1 tv520739_ex32-1.htm EX-32.1 3760
5 EXHIBIT 32.2 tv520739_ex32-2.htm EX-32.2 3635
  Complete submission text file 0001144204-19-025546.txt   2069452

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT atxi-20190331.xml EX-101.INS 492402
7 XBRL TAXONOMY EXTENSION SCHEMA atxi-20190331.xsd EX-101.SCH 18122
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atxi-20190331_cal.xml EX-101.CAL 16070
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20190331_def.xml EX-101.DEF 128231
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20190331_lab.xml EX-101.LAB 143174
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20190331_pre.xml EX-101.PRE 152376
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 19817800
SIC: 2834 Pharmaceutical Preparations